Kimberly Lathroum Joins Arcutis as Vice President of Marketing

WESTLAKE VILLAGE, Calif., March 23, 2020 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced that Kimberly Lathroum has joined the company as Vice President of Marketing. In this new role, Ms. Lathroum will be responsible for all of Arcutis? marketing efforts as the Company prepares for the potential future commercialization of its product candidates.

Click to view original post